Diamond TL, Grandhi A, Fuszard M, Xu Y, et al. Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations or M184I/V in Proviral DNA. J Infect Dis 2026 May 29:jiag257. doi: 10.1093.
PMID: 42213454